Login / Signup

Mid-term efficacy of the Cartiva synthetic cartilage implant in symptomatic hallux rigidus.

William R FletcherThomas CollinsAnna FoxAnand Pillai
Published in: Bone & joint open (2024)
This study represents the longest-term independent follow-up in the literature. It shows reassuring mid-term efficacy of the Cartiva SCI with better-than-expected survival. However, deterioration in scores for a subset of patients and lower satisfaction may predict ongoing failure in this group of patients. Additionally, males were noted to have a lower degree of improvement in scores than females. As such, ongoing observation of the SCI to assess durability and survivability, and identify predictive factors, is key to improving patient selection.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • spinal cord injury
  • systematic review
  • preterm infants